Brief: Guerbet Partners With Lausanne’S CHUV And CET To Launch Clinical Study
April 13 (Reuters) - Guerbet SA GRBT.PA :
* PARTNERS WITH LAUSANNE’S CHUV AND CET TO LAUNCH A CLINICAL
STUDY
* PARTNERS TO WORK TO CLARIFY IMMUNOMODULATORY AND
ACTIVATING
MECHANISMS INDUCED BY A CTACE PROCEDURE IN 20 PATIENTS WITH HCC
Source text: https://bit.ly/2GVhPKT
Further company coverage: GRBT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Q1 Revenue At EUR 177.4 Mln
Guerbet Q1 revenue up 2.6% at CER on increased volumes in EMEA and Asia
Medical imaging firm Guerbet's 2025 revenue falls on lower sales activity in France
Brief: Guerbet Says FDA Approves Labeling Update For Guerbet's Elucirem Injection
France's Guerbet misses 2025 revenue estimates